›› KLIFOVET › COMPANY › NEWS


Biotech is going to the dogs - KLIFOVET engaged in the development of novel therapies

REUTERs publishes article on novel therapies in animal health



Read about "Moose" a 6-year old English bulldog who gets treated with a cutting-edge biotechnology cancer treatment! The importance of novel therapies for the health of animals in recent and future years! Financial Post: "Biotech is going to the dogs - and big profits await" KLIFOVET's CEO cited in the articles deriving from Reuters Article.

https://uk.reuters.com/article/us-health-biotech-pets-focus/biotech-is-going-to-the-dogs-and-big-profits-await-idUKKBN1W414U

https://business.financialpost.com/pmn/business-pmn/biotech-is-going-to-the-dogs-and-big-profits-await